Impact of Hesperetin in Combination With Sucrose on Energy Metabolism
NCT05705596 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 33
Last updated 2023-11-28
Summary
The aim of this cross-over intervention study is to investigate the influence of the sweet-modulating substance hesperetin in combination with sucrose in comparison to an equally sweet-tasting sucrose-only solution on markers of energy metabolism.
Conditions
- Blood Glucose Fluctuations
- Hunger
Interventions
- OTHER
-
Sucrose
10% sucrose corresponding to a regular soft drink
- DRUG
-
Hesperetin
increases sweetness of 7% sucrose solution to match sweetness of 10% sucrose solution
Sponsors & Collaborators
-
University of Vienna
lead OTHER
Principal Investigators
-
Barbara Lieder, PhD · University of Vienna
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-01-31
- Primary Completion
- 2023-06-30
- Completion
- 2023-11-15
Countries
- Austria
Study Locations
More Related Trials
-
The Role of Apathy in Glycemic Control
NCT00844090 ·Status: COMPLETED ·Phase: NA
-
The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes
NCT01281228 ·Status: COMPLETED ·Phase: NA
-
The Therapeutic Effects of Topiramate and Metformin on Second Generation Antipsychotics-induced Obesity
NCT01384279 ·Status: COMPLETED ·Phase: NA
-
Adjunctive Low-dose Metformin in Patients With Schizophrenia and Metabolic Abnormalities
NCT02751307 ·Status: COMPLETED ·Phase: PHASE4
-
Examination of Bromocriptine on Homeostatic and Hedonic Mechanisms of Food Intake in Individuals at High Risk for T2DM
NCT05405244 ·Status: COMPLETED ·Phase: PHASE3
-
Bromocriptine and Insulin Sensitivity
NCT02428946 ·Status: COMPLETED ·Phase: NA
-
Evaluation Of Striatal Glucose Metabolism With Positron Emission Tomography Following PF-02545920 In Healthy Subjects
NCT01103726 ·Status: COMPLETED ·Phase: PHASE1
-
Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients
NCT02644577 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism
NCT01160991 ·Status: COMPLETED ·Phase: NA
-
Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?
NCT07109245 ·Status: RECRUITING ·Phase: PHASE4
-
Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness
NCT02167620 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of 5-Hydroxytryptophan (5-HTP) on Satiety
NCT00328913 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Herbal Products on Metabolism and Hunger
NCT00198952 ·Status: COMPLETED ·Phase: NA
-
Dopamine Action on Metabolism in Relation to Genotype
NCT03525002 ·Status: COMPLETED ·Phase: PHASE2
-
Brain Insulin Resistance in Mood Disorders
NCT03915613 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Haloperidol in Healthy Humans
NCT00625014 ·Status: COMPLETED ·Phase: NA
-
MEtformin and Lorcaserin for WeighT Loss in Schizophrenia
NCT02796144 ·Status: TERMINATED ·Phase: PHASE4
-
Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)
NCT01825798 ·Status: COMPLETED ·Phase: PHASE3
-
Strategies to Reduce Antipsychotic-Associated Weight Gain in Youth
NCT00617240 ·Status: COMPLETED ·Phase: PHASE2
-
Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia
NCT05748990 ·Status: RECRUITING ·Phase: NA
-
Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage
NCT01783717 ·Status: UNKNOWN ·Phase: NA
-
Molecular Mechanisms of Antipsychotic-induced Insulin Resistance
NCT02708394 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Dopamine and Insulin in Psychosis
NCT07252752 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Endogenous Opioid Activity and Affective State in Insulin Resistant Women
NCT02069379 ·Status: COMPLETED ·Phase: PHASE4
-
Substrate Metabolism and Insulin Sensitivity in Patients With Hyperprolactinemia Before and After Treatment
NCT00699530 ·Status: WITHDRAWN